Proficio Capital Partners LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1654175 NEWTON, MA

Position in VRTX

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$1,084,858

+$214,492 QoQ

Shares Held

2,184

+11.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#825

of 1,735 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Proficio Capital Partners LLC holds $4,501,972 across 8 Biotechnology names. VRTX ranks #2 (24.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYMR	Kymera Therapeutics, Inc.	11,045	$1,266,530
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	2,184	$1,084,858
3	REGN	Regeneron Pharmaceuticals, Inc.	909	$566,797
4	INCY	Incyte Corp	4,483	$508,192
5	JAZZ	Jazz Pharmaceuticals plc	1,786	$430,372
6	MRNA	Moderna, Inc.	4,251	$297,697
7	ALNY	Alnylam Pharmaceuticals, Inc.	919	$276,646
8	FATE	Fate Therapeutics Inc	26,252	$70,880

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,084,858	2,184	+11.7%	Shares	Sole	2026-08-17
2025-06-30	$870,366	1,955	-6.0%	Shares	Sole	2025-08-07
2025-03-31	$1,007,940	2,079	+112.6%	Shares	Sole	2025-05-06
2024-12-31	$393,840	978	+46.6%	Shares	Sole	2025-02-06
2024-09-30	$310,208	667	-21.2%	Shares	Sole	2024-11-01
2024-06-30	$396,537	846	+2.8%	Shares	Sole	2024-07-25
2024-03-31	$344,022	823	+4.3%	Shares	Sole	2024-05-02
2023-12-31	$321,036	789	-0.5%	Shares	Sole	2024-02-13
2023-09-30	$275,757	793	+10.1%	Shares	Sole	2023-10-18
2023-06-30	$253,375	720	+4.7%	Shares	Sole	2023-08-14
2023-03-31	$216,768	688	-9.1%	Shares	Sole	2023-04-21
2020-09-30	$205,994	757	+3.0%	Shares	Sole	2020-11-02
2020-06-30	$213,377	735	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.